Matches in Wikidata for { <http://www.wikidata.org/entity/Q74632921> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q74632921 description "article scientifique publié en 1999" @default.
- Q74632921 description "artikull shkencor i botuar më 01 shkurt 1999" @default.
- Q74632921 description "artículu científicu espublizáu en febreru de 1999" @default.
- Q74632921 description "im Februar 1999 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74632921 description "scientific article published on 01 February 1999" @default.
- Q74632921 description "wetenschappelijk artikel" @default.
- Q74632921 description "наукова стаття, опублікована в лютому 1999" @default.
- Q74632921 name "In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia" @default.
- Q74632921 name "In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia" @default.
- Q74632921 name "In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia" @default.
- Q74632921 type Item @default.
- Q74632921 label "In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia" @default.
- Q74632921 label "In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia" @default.
- Q74632921 label "In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia" @default.
- Q74632921 prefLabel "In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia" @default.
- Q74632921 prefLabel "In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia" @default.
- Q74632921 prefLabel "In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia" @default.
- Q74632921 P1433 Q74632921-53E4617B-9DC2-4E90-A333-BCC59CC1663D @default.
- Q74632921 P1476 Q74632921-0FE34CC9-9F5D-4574-BB4D-328A751F52F4 @default.
- Q74632921 P2093 Q74632921-14F431D4-3887-48EB-9145-5708C5C1070D @default.
- Q74632921 P2093 Q74632921-A77408F5-3841-4A1B-90AE-61FA591D5FCC @default.
- Q74632921 P2093 Q74632921-DC1C3E71-87BF-4D57-9017-69A869A50E6E @default.
- Q74632921 P2860 Q74632921-42B832CA-D1C7-41EA-BC26-DF2939047442 @default.
- Q74632921 P2860 Q74632921-5EF2E62B-9D0B-4B90-A27E-C1D14590BDCD @default.
- Q74632921 P2860 Q74632921-66BC38BE-ACA5-48BA-BA46-09F3972A848E @default.
- Q74632921 P2860 Q74632921-C658DB88-9071-42DD-9957-054AC7F09EB4 @default.
- Q74632921 P2860 Q74632921-CEF921EC-56D8-45BA-AB00-F475F5CB5982 @default.
- Q74632921 P2860 Q74632921-D819496B-2FB4-4D2F-BBBA-891E16C29361 @default.
- Q74632921 P2860 Q74632921-FA24E7F5-96CB-492D-8AE6-9DCF2F9C0D3A @default.
- Q74632921 P304 Q74632921-96371F3F-9F14-41C0-A09A-165CC291BB64 @default.
- Q74632921 P31 Q74632921-EA058AF3-DF3D-4E60-95B0-66CA4B19A04D @default.
- Q74632921 P356 Q74632921-E8160D5A-A72E-44BD-B196-A86DF17691E2 @default.
- Q74632921 P433 Q74632921-F4F2DC66-FCFA-4A33-9CE4-01BC7E350141 @default.
- Q74632921 P478 Q74632921-F1F6E74D-661D-4587-9656-12115452ECF9 @default.
- Q74632921 P577 Q74632921-D912B12B-9114-4EE5-94C7-A57D838CC709 @default.
- Q74632921 P698 Q74632921-4461D82B-FF4B-410E-A9AB-D0BB55304C7F @default.
- Q74632921 P921 Q74632921-21600C84-3A4A-4BD6-A96F-84F55B8A0485 @default.
- Q74632921 P921 Q74632921-87FDEB8A-5057-43A3-8E5A-1FFB5F22AF34 @default.
- Q74632921 P921 Q74632921-8B014A66-8C6B-472D-9612-A520E9D6DE23 @default.
- Q74632921 P921 Q74632921-FD780EC5-12C4-49A1-BE0F-3E2823777F84 @default.
- Q74632921 P356 S0732-8893(98)00126-6 @default.
- Q74632921 P698 10091030 @default.
- Q74632921 P1433 Q15763479 @default.
- Q74632921 P1476 "In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia" @default.
- Q74632921 P2093 "H D Isenberg" @default.
- Q74632921 P2093 "K France" @default.
- Q74632921 P2093 "P Alperstein" @default.
- Q74632921 P2860 Q28327424 @default.
- Q74632921 P2860 Q36086973 @default.
- Q74632921 P2860 Q39816839 @default.
- Q74632921 P2860 Q50463793 @default.
- Q74632921 P2860 Q70178739 @default.
- Q74632921 P2860 Q70725806 @default.
- Q74632921 P2860 Q73508339 @default.
- Q74632921 P304 "81-86" @default.
- Q74632921 P31 Q13442814 @default.
- Q74632921 P356 "10.1016/S0732-8893(98)00126-6" @default.
- Q74632921 P433 "2" @default.
- Q74632921 P478 "33" @default.
- Q74632921 P577 "1999-02-01T00:00:00Z" @default.
- Q74632921 P698 "10091030" @default.
- Q74632921 P921 Q139227 @default.
- Q74632921 P921 Q142705 @default.
- Q74632921 P921 Q31856 @default.
- Q74632921 P921 Q424193 @default.